Chimeric Vaccines Based on Novel Insect-Specific Flaviviruses

Vector-borne flaviviruses are responsible for nearly half a billion human infections worldwide each year, resulting in millions of cases of debilitating and severe diseases and approximately 115,000 deaths. While approved vaccines are available for some of these viruses, the ongoing efficacy, safety...

Descripción completa

Detalles Bibliográficos
Autores principales: Harrison, Jessica J., Hobson-Peters, Jody, Bielefeldt-Ohmann, Helle, Hall, Roy A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8623431/
https://www.ncbi.nlm.nih.gov/pubmed/34835160
http://dx.doi.org/10.3390/vaccines9111230

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8623431/
https://www.ncbi.nlm.nih.gov/pubmed/34835160
http://dx.doi.org/10.3390/vaccines9111230

Ejemplares similares